Patent details

Basic Information

Publication number:

EP4385509

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP231763665

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MIGALASTAT DOSAGE REGIMEN HAVING IMPROVED PHARMACOKINETICS

French Title of Invention:

SCHÉMA POSOLOGIQUE DE MIGALASTAT À PHARMACOCINÉTIQUE AMÉLIORÉE

German Title of Invention:

MIGALASTAT DOSIERUNGSSCHEMA MIT VERBESSERTER PHARMAKOKINETIK

SPC Number:

Dates

Filing date:

31/05/2023

Grant date:

03/09/2025

EP Publication Date:

19/06/2024

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/09/2025

EP B1 Publication Date:

03/09/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

31/05/2043

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/08/2025

 

 

Name:

Amicus Therapeutics, Inc.

Address:

3675 Market Street, Philadelphia, PA 19104, United States (US)

Inventor

Name:

JOHNSON, Franklin

Address:

United States (US)

Priority

1

Priority Number:

202263432235 P

Priority Date:

13/12/2022

Priority Country:

United States (US)

2

Priority Number:

202318315928

Priority Date:

11/05/2023

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/445; A61K 31/522; A61P 3/00;

Publication

European Patent Bulletin

Issue number:

202536

Publication date:

03/09/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

4

Annual Fee Amount:

41 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages